Cardlytics (CDLX) Expected to Post Quarterly Earnings on Thursday

Cardlytics (NASDAQ:CDLX) is anticipated to issue its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of ($1.93) per share and revenue of $37.07 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.80. The company had revenue of $36.88 million for the quarter, compared to the consensus estimate of $37.00 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 55.92%. On average, analysts expect Cardlytics to post ($3.89) EPS for the current fiscal year and $1.90 EPS for the next fiscal year.

Cardlytics Stock Performance

NASDAQ:CDLX opened at $2.09 on Wednesday. The firm has a market capitalization of $12.14 million, a price-to-earnings ratio of -0.11 and a beta of 0.79. Cardlytics has a 52-week low of $1.57 and a 52-week high of $18.90. The stock has a fifty day moving average of $2.94 and a 200 day moving average of $6.12.

Insider Transactions at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 10,351 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $2.71, for a total value of $28,051.21. Following the completion of the transaction, the chief executive officer owned 146,288 shares of the company’s stock, valued at $396,440.48. The trade was a 6.61% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 31,194 shares of company stock worth $100,568 in the last three months. Insiders own 5.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CDLX. Wall Street Zen lowered Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, September 19th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, October 2nd. One analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell” and a consensus price target of $10.00.

About Cardlytics

Cardlytics, Inc is a financial technology and advertising company that operates a marketing platform through banks and other financial institutions. Its technology connects consumers with targeted merchant offers based on transaction data, while providing advertisers with a way to reach customers through digital banking applications and other financial channels.

The company’s platform supports merchant-funded rewards, cash-back promotions and purchase-based advertising. Participating consumers can receive offers from retailers, restaurants, travel providers and other businesses, while advertisers can use Cardlytics’ data and measurement tools to target audiences and evaluate whether campaigns lead to purchases.

Cardlytics was founded in 2008 by Scott Grimes and Lynne Laube and is headquartered in Atlanta, Georgia.